TickerFactsScreenerDevelopers

Akebia Therapeutics, Inc. (AKBA) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2013: $3.91M2014: $6.92M2015: $11.94M2016: $232.10M2017: $241.67M2018: $360.61M2019: $376.44M2020: $396.52M2021: $455.34M2022: $350.82M2023: $272.29M2024: $269.86M2025: $343.95M$343.95M
2013Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$343.95M+27.5%
2024$269.86M-0.9%
2023$272.29M-22.4%
2022$350.82M-23.0%
2021$455.34M+14.8%
2020$396.52M+5.3%
2019$376.44M+4.4%
2018$360.61M+49.2%
2017$241.67M+4.1%
2016$232.10M+1843.5%
2015$11.94M+72.6%
2014$6.92M+76.9%
2013$3.91M—